'Monsters' actor advocates for retrial of murder-convict Menendez brothers
Nathan Lane, the Emmy-winning star who plays journalist Dominick Dunne in Netflix's Monsters: The Lyle and Erik Menendez Story, is backing a retrial for the Menendez brothers. Even though the series has faced backlash from Erik and his family over its take on real-life events, it's still one of Netflix's most streamed shows. In an interview with PEOPLE, Lane said all the buzz around Monsters "may work in their favor" for another trial.
Lane defended 'Monsters' amid criticism
In response to Erik's criticism, which he called "rooted in horrible and blatant lies," Lane defended Monsters by stating, "It's a dramatization, it's not a documentary." "Not everyone is going to agree with every single point of view, but that's what makes horse races. I think they certainly cover the fact that they were abused." Meanwhile, executive producer Ryan Murphy also defended his series by stating that 60-65% of their show centers around the alleged abuse faced by the brothers.
Lane's views on the Menendez case
Lane has also weighed in on the Menendez case, sharing that he believes the brothers were sexually abused. "There were extenuating circumstances in what was happening to them from a very early age — fear and physical and emotional abuse." "They've served 35 years. They may not like how they were portrayed, it may actually help. We didn't get two thumbs up from prison, but they may revisit the trial. I think they deserve that."
'Monsters' explores Menendez brothers' controversial trial
Monsters delves into the story of Erik and Lyle Menendez, who were convicted for the murder of their parents in 1989. The brothers claimed they were sexually abused by their father, leading to their violent act. After two trials, they were found guilty of first-degree murder in October 1995 and are currently serving life sentences at the Richard J Donovan Correctional Facility in San Diego. Recently, Cooper Koch, who plays Eric in the show, also expressed hope for a re-trial.